Oxford Asset Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-201,746
| Closed | -$1.76M | – | 1486 |
|
|
2019
Q4 | $1.76M | Buy |
201,746
+88,498
| +78% | +$772K | 0.05% | 499 |
|
|
2019
Q3 | $377K | Sell |
113,248
-25,082
| -18% | -$83.5K | 0.01% | 1366 |
|
|
2019
Q2 | $685K | Buy |
138,330
+8,541
| +7% | +$42.3K | 0.01% | 1142 |
|
|
2019
Q1 | $805K | Buy |
129,789
+87,558
| +207% | +$543K | 0.02% | 1030 |
|
|
2018
Q4 | $142K | Buy |
+42,231
| New | +$142K | ﹤0.01% | 1606 |
|
|
2018
Q1 | – | Sell |
-73,311
| Closed | -$966K | – | 1952 |
|
|
2017
Q4 | $966K | Buy |
73,311
+13,771
| +23% | +$181K | 0.02% | 953 |
|
|
2017
Q3 | $927K | Buy |
59,540
+6,328
| +12% | +$98.5K | 0.02% | 969 |
|
|
2017
Q2 | $747K | Buy |
+53,212
| New | +$747K | 0.01% | 984 |
|